<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK7046" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK7046/" /><meta name="ncbi_pagename" content="COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="COL4A1-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/07/07" /><meta name="citation_author" content="Emmanuelle Plaisier" /><meta name="citation_author" content="Pierre Ronco" /><meta name="citation_pmid" content="20301768" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK7046/" /><meta name="citation_keywords" content="Autosomal Dominant Familial Porencephaly" /><meta name="citation_keywords" content="Autosomal Dominant Brain Small-Vessel Disease with Hemorrhage" /><meta name="citation_keywords" content="Hereditary Angiopathy with Nephropathy, Aneurysms, and Muscle Cramps (HANAC) Syndrome" /><meta name="citation_keywords" content="Tortuosity of Retinal Arteries" /><meta name="citation_keywords" content="Nonsyndromic Autosomal Dominant Congenital Cataract" /><meta name="citation_keywords" content="Collagen alpha-1(IV) chain" /><meta name="citation_keywords" content="COL4A1" /><meta name="citation_keywords" content="COL4A1-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="COL4A1-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Emmanuelle Plaisier" /><meta name="DC.Contributor" content="Pierre Ronco" /><meta name="DC.Date" content="2016/07/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK7046/" /><meta name="description" content="The spectrum of COL4A1-related disorders includes: small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages. Clinically, small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura. Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability; however, on occasion it can be an incidental finding. HANAC (hereditary angiopathy with nephropathy, aneurysms, and muscle cramps) syndrome usually associates asymptomatic small-vessel brain disease, cerebral large vessel involvement (i.e., aneurysms), and systemic findings involving the kidney, muscle, and small vessels of the eye. Two additional phenotypes include isolated retinal artery tortuosity and nonsyndromic autosomal dominant congenital cataract." /><meta name="og:title" content="COL4A1-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="The spectrum of COL4A1-related disorders includes: small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages. Clinically, small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura. Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability; however, on occasion it can be an incidental finding. HANAC (hereditary angiopathy with nephropathy, aneurysms, and muscle cramps) syndrome usually associates asymptomatic small-vessel brain disease, cerebral large vessel involvement (i.e., aneurysms), and systemic findings involving the kidney, muscle, and small vessels of the eye. Two additional phenotypes include isolated retinal artery tortuosity and nonsyndromic autosomal dominant congenital cataract." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK7046/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/col4a1-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK7046/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88F16AE03FE8E1000000000A3C0398.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK7046_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK7046_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/oi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hdls/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK7046_"><span class="title" itemprop="name"><i>COL4A1</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Emmanuelle Plaisier</span>, MD, PhD and <span itemprop="author">Pierre Ronco</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK7046_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK7046_ai__"><div class="contrib half_rhythm"><span itemprop="author">Emmanuelle Plaisier</span>, MD, PhD<div class="affiliation small">Department of Nephrology and Dialysis INSERM UMR S1155<br />H&#x000f4;pital Tenon<br />Universit&#x000e9; Pierre et Marie Curie<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.phpa@reisialp.elleunamme" class="oemail">rf.phpa@reisialp.elleunamme</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Pierre Ronco</span>, MD, PhD<div class="affiliation small">Department of Nephrology and Dialysis INSERM UMR S1155<br />H&#x000f4;pital Tenon<br />Universit&#x000e9; Pierre et Marie Curie<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.oohay@ocnorerreip" class="oemail">rf.oohay@ocnorerreip</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 25, 2009</span>; Last Update: <span itemprop="dateModified">July 7, 2016</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="col4a1-dis.Summary" itemprop="description"><h2 id="_col4a1-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The spectrum of <i>COL4A1</i>-related disorders includes: small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages. Clinically, small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> migraine with aura. Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability; however, on occasion it can be an incidental finding. HANAC (<i>h</i>ereditary <i>a</i>ngiopathy with <i>n</i>ephropathy, <i>a</i>neurysms, and muscle <i>c</i>ramps) syndrome usually associates asymptomatic small-vessel brain disease, cerebral large vessel involvement (i.e., aneurysms), and systemic findings involving the kidney, muscle, and small vessels of the eye. Two additional phenotypes include isolated retinal artery tortuosity and nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is based on clinical findings and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>COL4A1</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Supportive care tailored to the individual&#x02019;s specific medical needs and including practical help and emotional support for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and their families. Hypertension should be treated to reduce the overall risk of stroke.</p><p><i>Prevention of primary and secondary complications:</i> Avoiding head trauma and anticoagulant exposure may decrease the risk for intracerebral hemorrhage.</p><p><i>Surveillance:</i> Depends on the severity and type of symptoms.</p><p><i>Agents/circumstances to avoid:</i> Smoking and hypertension because these factors increase the risk for stroke; sustained head pressure or physical activities that may cause head trauma; anticoagulant use.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>COL4A1</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with a <i>COL4A1</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is estimated to be at least 27%. Each child of an individual with a <i>COL4A1</i>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis is possible for pregnancies at increased risk if the pathogenic variant in the family is known.</p></div></div><div id="col4a1-dis.GeneReview_Scope"><h2 id="_col4a1-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="col4a1-dis.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7046/table/col4a1-dis.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__col4a1-dis.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_col4a1-dis.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL4A1</i>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_col4a1-dis.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Autosomal dominant <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porencephaly</div></li><li class="half_rhythm"><div>Autosomal dominant brain small-vessel disease with hemorrhage</div></li><li class="half_rhythm"><div>Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) syndrome</div></li><li class="half_rhythm"><div>Tortuosity of retinal arteries</div></li><li class="half_rhythm"><div>Nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="col4a1-dis.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#col4a1-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="col4a1-dis.Diagnosis"><h2 id="_col4a1-dis_Diagnosis_">Diagnosis</h2><p><i>COL4A1</i>-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum creatine kinase (CK) elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia).</p><div id="col4a1-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A <i>COL4A1</i>-related disorder <b>should be suspected</b> in individuals with any of the following phenotypes that have overlapping features:</p><ul><li class="half_rhythm"><div>Porencephaly type 1 [<a class="bk_pop" href="#col4a1-dis.REF.gould.2005.1167">Gould et al 2005</a>, <a class="bk_pop" href="#col4a1-dis.REF.breedveld.2006.490">Breedveld et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>]</div></li><li class="half_rhythm"><div>Brain small-vessel disease with or without ocular anomalies [<a class="bk_pop" href="#col4a1-dis.REF.gould.2006.1489">Gould et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.coupry.2010.483">Coupry et al 2010</a>, <a class="bk_pop" href="#col4a1-dis.REF.shah.2012.569">Shah et al 2012</a>, <a class="bk_pop" href="#col4a1-dis.REF.r_dahl.2013.946">R&#x000f8;dahl et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>]</div></li><li class="half_rhythm"><div>HANAC (<i>h</i>ereditary <i>a</i>ngiopathy with <i>n</i>ephropathy, <i>a</i>neurysms, and muscle <i>c</i>ramps) syndrome [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</a>]</div></li><li class="half_rhythm"><div>Tortuosity of retinal arteries [<a class="bk_pop" href="#col4a1-dis.REF.zenteno.2014.1789">Zenteno et al 2014</a>]</div></li><li class="half_rhythm"><div>Nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract [<a class="bk_pop" href="#col4a1-dis.REF.xia.2014.97">Xia et al 2014</a>]</div></li></ul><p><b>Clinical features</b> of <i>COL4A1</i>-related disorders vary widely and can include the following:</p><ul><li class="half_rhythm"><div>Neurologic</div><ul><li class="half_rhythm"><div>Infantile hemiplegia</div></li><li class="half_rhythm"><div>Developmental delay</div></li><li class="half_rhythm"><div>Migraines with or without aura</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Intracerebral hemorrhage at any age including antenatal, neonatal, and recurrent episodes</div></li><li class="half_rhythm"><div>Ischemic stroke</div></li><li class="half_rhythm"><div>Typically on neuroimaging: features of brain small-vessel disease (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" rid-figpopup="figcol4a1disF1" rid-ob="figobcol4a1disF1">Figure 1</a>)</div></li></ul></li><li class="half_rhythm"><div>Ophthalmic</div><ul><li class="half_rhythm"><div>Transient visual loss caused by retinal hemorrhage</div></li><li class="half_rhythm"><div>Cataract, glaucoma, microphthalmia/anophthalmia</div></li></ul></li><li class="half_rhythm"><div>Other systemic findings</div><ul><li class="half_rhythm"><div>Hematuria</div></li><li class="half_rhythm"><div>Raynaud phenomenon</div></li><li class="half_rhythm"><div>Supraventricular arrhythmia</div></li><li class="half_rhythm"><div>Muscle cramps</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcol4a1disF1" co-legend-rid="figlgndcol4a1disF1"><a href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figcol4a1disF1" rid-ob="figobcol4a1disF1"><img class="small-thumb" src="/books/NBK7046/bin/col4a1-dis-Image001.gif" src-large="/books/NBK7046/bin/col4a1-dis-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndcol4a1disF1"><h4 id="col4a1-dis.F1"><a href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" rid-ob="figobcol4a1disF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Spectrum of brain imaging abnormalities in <i>COL4A1</i>-related disorders A. Axial FLAIR showing right paraventricular porencephalic cyst and extensive white-matter abnormalities [van der Knaap et al 2006]</p></div></div><p><b>Family history</b> is consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Findings and age of onset vary within and between families.</p></div><div id="col4a1-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>COL4A1</i>-related disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a href="#col4a1-dis.Suggestive_Findings">suggestive findings</a> and the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>COL4A1</i> (see <a class="figpopup" href="/books/NBK7046/table/col4a1-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figcol4a1disTmoleculargenetictestingu" rid-ob="figobcol4a1disTmoleculargenetictestingu">Table 1</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>COL4A1</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found. To date, no deletions or duplications involving <i>COL4A1</i> as causative of <i>COL4A1</i>-related disorders have been reported. Because these disorders usually result from a <i>COL4A1</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant that disrupts the collagen triple helix (see <a href="#col4a1-dis.Molecular_Genetics">Molecular Genetics</a>), a screening test for large duplications/deletions may have a very low yield.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>COL4A1</i> and other genes of interest (see <a href="#col4a1-dis.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>COL4A1</i>) fails to confirm a diagnosis in an individual with features of a <i>COL4A1</i>-related disorder. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="col4a1-dis.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>COL4A1</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7046/table/col4a1-dis.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__col4a1-dis.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL4A1</i></td><td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="col4a1-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK7046/#col4a1-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="col4a1-dis.TF.1.2"><p class="no_margin">See <a href="#col4a1-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="col4a1-dis.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="col4a1-dis.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="col4a1-dis.TF.1.5"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="col4a1-dis.Clinical_Characteristics"><h2 id="_col4a1-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="col4a1-dis.Clinical_Description"><h3>Clinical Description</h3><p><i>COL4A1</i>-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum CK elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, hemolytic anemia).</p><div id="col4a1-dis.Autosomal_Dominant_Familial_P"><h4>Autosomal Dominant Familial Porencephaly</h4><p>Autosomal dominant <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porencephaly related to <i>COL4A1</i> pathogenic variants has been reported in more than 50 individuals [<a class="bk_pop" href="#col4a1-dis.REF.gould.2005.1167">Gould et al 2005</a>, <a class="bk_pop" href="#col4a1-dis.REF.breedveld.2006.490">Breedveld et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>]. This condition is characterized by the presence of fluid-filled cavities in the brain, caused by antenatal or perinatal parenchymal hemorrhage and detected by either brain CT, MRI (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" rid-figpopup="figcol4a1disF1" rid-ob="figobcol4a1disF1">Figure 1A</a>), or fetal ultrasound imaging. In addition to porencephalic cavities, brain imaging shows various degrees of periventricular leukoencephalopathy, microbleeds, lacunar infarct, and calcifications [<a class="bk_pop" href="#col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.livingston.2011.227">Livingston et al 2011</a>, <a class="bk_pop" href="#col4a1-dis.REF.ayrignac.2015.284">Ayrignac et al 2015</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</p><p>The spectrum of neurologic clinical symptoms varies in degree of severity and age of onset, with wide intrafamilial heterogeneity. Typically, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may present with infantile hemiparesis, seizures, intellectual disability, dystonia, stroke, and migraine. First manifestations (including intracerebral hemorrhages) may occur in previously asymptomatic adults, and MRI brain anomalies can be clinically silent.</p><p>Congenital cataract is frequently observed in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Retinal arteriolar tortuosity is more rarely associated with porencephaly [<a class="bk_pop" href="#col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</a>].</p></div><div id="col4a1-dis.Autosomal_Dominant_Brain_Smal"><h4>Autosomal Dominant Brain Small-Vessel Disease with Hemorrhage</h4><p>Autosomal dominant brain small-vessel disease with hemorrhage differs from <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> porencephaly by the absence of porencephalic cavities, while brain imaging demonstrates characteristic brain small-vessel involvement, including diffuse periventricular leukoencephalopathy (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" rid-figpopup="figcol4a1disF1" rid-ob="figobcol4a1disF1">Figure 1B</a>), lacunar infarcts, microbleeds, dilated perivascular spaces, deep intracerebral hemorrhages, and intracerebral calcifications (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" rid-figpopup="figcol4a1disF1" rid-ob="figobcol4a1disF1">Figure 1C</a>) [<a class="bk_pop" href="#col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</p><p>Neurologic manifestations are also heterogeneous within families, and vary from infantile hemiparesis with seizure to <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> migraine with aura to absence of clinical symptoms. Single or recurrent intracerebral hemorrhage may occur in non-hypertensive adults who are younger than age 50 years. Such hemorrhages can occur spontaneously, after trauma, or as a result of anticoagulant use; some are fatal. Antenatal intracerebral and intraventricular hemorrhage may be observed using fetal ultrasound examination. Mild cognitive impairment has also been reported in one family [<a class="bk_pop" href="#col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</a>]; however, it is unclear whether this is a separate finding or a manifestation of recurrent stroke.</p><p>Concomitant eye anomalies including retinal arteriolar tortuosity, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract, and/or anterior segment anomalies of the Axenfeld-Rieger type may be observed [<a class="bk_pop" href="#col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.coupry.2010.483">Coupry et al 2010</a>].</p><p>More rarely, systemic symptoms including serum CK elevation with or without muscle cramps [<a class="bk_pop" href="#col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>] and renal involvement including hematuria, unilateral renal atrophy [<a class="bk_pop" href="#col4a1-dis.REF.john.2015.19">John et al 2015</a>], renal cysts, and hemolytic anemia [<a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>] are observed.</p></div><div id="col4a1-dis.HANAC_Syndrome"><h4>HANAC Syndrome</h4><p>HANAC (<i>h</i>ereditary <i>a</i>ngiopathy with <i>n</i>ephropathy, <i>a</i>neurysms, and muscle <i>c</i>ramps) syndrome has been well characterized in six families [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</a>].</p><p>The small-vessel brain disease of HANAC is usually clinically asymptomatic [<a class="bk_pop" href="#col4a1-dis.REF.alamowitch.2009.1873">Alamowitch et al 2009</a>]. By contrast, the systemic symptoms usually observed in HANAC &#x02013; including muscle cramps, renal involvement, retinal arterial tortuosity, and Raynaud phenomenon &#x02013; are rarely reported in <i>COL4A1</i>-related porencephaly or small-vessel brain disease [<a class="bk_pop" href="#col4a1-dis.REF.gould.2006.1489">Gould et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</p><p><b>Brain involvement</b></p><ul><li class="half_rhythm"><div>Half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have: cerebral small-vessel disease characterized by leukoencephalopathy affecting subcortical, periventricular, or pontine regions; dilated perivascular spaces; lacunar infarcts; and microbleeds. None have porencephaly. Only two of the 14 affected individuals have clinical cerebrovascular symptoms: a minor ischemic stroke and a mild post-traumatic intracerebral hemorrhage while on anticoagulants [<a class="bk_pop" href="#col4a1-dis.REF.alamowitch.2009.1873">Alamowitch et al 2009</a>].</div></li><li class="half_rhythm"><div>Single or multiple intracranial aneurysms, all located on the carotid siphon, have been observed in six individuals, with no rupture episode (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F1/?report=objectonly" target="object" rid-figpopup="figcol4a1disF1" rid-ob="figobcol4a1disF1">Figure 1D</a>).</div></li></ul><p><b>Renal manifestations</b></p><ul><li class="half_rhythm"><div>One family presented with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> microscopic hematuria (i.e., without proteinuria or hypertension) and intermittent episodes of gross hematuria. Kidney biopsy was normal by light microscopy, but ultrastructural examination disclosed irregular and abnormal thickening of the basement membranes of the tubules, Bowman&#x02019;s capsule, and interstitial capillaries. Small renal cysts were variably observed.</div></li><li class="half_rhythm"><div>Three families had renal findings of bilateral cortical and medullary renal cysts without hematuria. Cysts were large, but the overall kidney size was normal (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F2/?report=objectonly" target="object" rid-figpopup="figcol4a1disF2" rid-ob="figobcol4a1disF2">Figure 2</a>). Mild renal failure without proteinuria or hypertension may develop in individuals after age 50 years.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcol4a1disF2" co-legend-rid="figlgndcol4a1disF2"><a href="/books/NBK7046/figure/col4a1-dis.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figcol4a1disF2" rid-ob="figobcol4a1disF2"><img class="small-thumb" src="/books/NBK7046/bin/col4a1-dis-Image002.gif" src-large="/books/NBK7046/bin/col4a1-dis-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndcol4a1disF2"><h4 id="col4a1-dis.F2"><a href="/books/NBK7046/figure/col4a1-dis.F2/?report=objectonly" target="object" rid-ob="figobcol4a1disF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Abdominal MRI showing bilateral renal cysts in a patient with HANAC syndrome [Plaisier et al 2007] </p></div></div><p><b>Muscle cramps</b> involving a variety of muscles usually occur in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, with first episodes occurring before age three years. Muscle strength was slightly affected in only two individuals. Electromyography does not show a specific abnormality, and muscle biopsy, available in one person only, is normal. All affected individuals have persistent elevation of serum CK concentration.</p><p><b>Bilateral retinal arteriolar tortuosity</b> is observed in all individuals with HANAC syndrome (see <b>Ocular manifestations</b> below).</p><p><b>Other manifestations.</b> Raynaud phenomenon, supraventricular arrhythmia, and liver cyst are variably reported.</p></div><div id="col4a1-dis.Additional_Findings_in_COL4A1"><h4>Additional Findings in <i>COL4A1</i>-Related Disorders</h4><p><b>Ocular manifestations</b> are variably observed in <i>COL4A1</i>-related disorders. Three distinct ocular features have been reported:</p><ul><li class="half_rhythm"><div><b>Bilateral retinal arterial tortuosity</b> is variably present in individuals with small-vessel brain disease with hemorrhage [<a class="bk_pop" href="#col4a1-dis.REF.gould.2006.1489">Gould et al 2006</a>] or with porencephaly [<a class="bk_pop" href="#col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</a>], whereas all individuals with HANAC syndrome exhibited this finding [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</a>]. Additionally, one <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been characterized in individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> retinal arteriolar tortuosity without cerebral or systemic symptoms [<a class="bk_pop" href="#col4a1-dis.REF.zenteno.2014.1789">Zenteno et al 2014</a>]. Fundus examination shows marked tortuosity of second- and third-order retinal arteries, with normal first-order arteries and retinal veins (<a class="figpopup" href="/books/NBK7046/figure/col4a1-dis.F3/?report=objectonly" target="object" rid-figpopup="figcol4a1disF3" rid-ob="figobcol4a1disF3">Figure 3</a>). No leakage or staining is observed on fluorescein angiography. Affected individuals experience episodic transient visual loss as a result of retinal hemorrhage occurring spontaneously or after minor stress or trauma. Visual prognosis has been excellent, without retinal sequelae.</div></li><li class="half_rhythm"><div><b>Congenital cataract</b> is reported either as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> ocular feature [<a class="bk_pop" href="#col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</a>, <a class="bk_pop" href="#col4a1-dis.REF.shah.2010.182">Shah et al 2010</a>] or associated with other eye anterior segment abnormalities of Axenfeld-Rieger type in families with small-vessel brain disease and porencephaly [<a class="bk_pop" href="#col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.coupry.2010.483">Coupry et al 2010</a>, <a class="bk_pop" href="#col4a1-dis.REF.r_dahl.2013.946">R&#x000f8;dahl et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>]. Nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataract has also been associated with a <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a large family [<a class="bk_pop" href="#col4a1-dis.REF.xia.2014.97">Xia et al 2014</a>].</div></li><li class="half_rhythm"><div><b>Anterior segment anomaly of Axenfeld-Rieger type</b> comprises a spectrum of ocular findings affecting the anterior chamber including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> iris abnormalities, posterior embryotoxon, microcornea, increased intraocular pressure, and glaucoma. It has been described in families presenting with small-vessel brain disease and porencephaly [<a class="bk_pop" href="#col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcol4a1disF3" co-legend-rid="figlgndcol4a1disF3"><a href="/books/NBK7046/figure/col4a1-dis.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figcol4a1disF3" rid-ob="figobcol4a1disF3"><img class="small-thumb" src="/books/NBK7046/bin/col4a1-dis-Image003.gif" src-large="/books/NBK7046/bin/col4a1-dis-Image003.jpg" alt="Figure 3. . Fluorescein angiography." /></a><div class="icnblk_cntnt" id="figlgndcol4a1disF3"><h4 id="col4a1-dis.F3"><a href="/books/NBK7046/figure/col4a1-dis.F3/?report=objectonly" target="object" rid-ob="figobcol4a1disF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Fluorescein angiography. Typical retinal arteriolar tortuosity (arrows) in a patient with HANAC syndrome [Plaisier et al 2007]. </p></div></div><p><b>Renal manifestations</b></p><ul><li class="half_rhythm"><div><b>Bilateral renal cysts</b> are very frequently observed in individuals with HANAC, and more rarely in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with small-vessel brain disease. In one family, renal cysts represent the main clinical manifestation, together with hematuria and glomerular filtration rate decrease [<a class="bk_pop" href="#col4a1-dis.REF.gale.2016.1908">Gale et al 2016</a>].</div></li><li class="half_rhythm"><div><b>Hematuria</b> has been reported in individuals with porencephaly, small-vessel brain disease, and HANAC [<a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</div></li><li class="half_rhythm"><div><b>Unilateral renal atrophy</b> has been reported in two individuals [<a class="bk_pop" href="#col4a1-dis.REF.john.2015.19">John et al 2015</a>].</div></li><li class="half_rhythm"><div><b>Glomerular filtration rate decrease</b> (usually affecting individuals age &#x0003e;40 years) has been observed in individuals with HANAC, as well as in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from one family presenting with renal cysts and hematuria without brain or extracerebral involvement [<a class="bk_pop" href="#col4a1-dis.REF.john.2015.19">John et al 2015</a>, <a class="bk_pop" href="#col4a1-dis.REF.gale.2016.1908">Gale et al 2016</a>].</div></li></ul><p><b>Muscle manifestations.</b> Serum CK elevation and painful muscle cramps, seen in all individuals with HANAC syndrome [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</a>], are only variably present in other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>]. Muscle biopsy was performed in one affected individual with myopathic defects [<a class="bk_pop" href="#col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</a>].</p><p><b>Cardiac manifestations.</b> Mitral valve prolapse and supraventricular arrythmia have been characterized in four patients [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</p><p><b>Ultrastructural basement membrane abnormalities</b> have been demonstrated in skin vessels, at the dermo-epidermal junction, and in kidney.</p><ul><li class="half_rhythm"><div>In individuals with HANAC syndrome with hematuria, ultrastructural examination disclosed irregular and abnormal thickening of the basement membranes of the tubules, Bowman&#x02019;s capsule, and interstitial capillaries [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</a>]. In the skin, similar alterations including <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of the basement membrane are seen at the dermo-epidermal junction and in dermal arterioles; vascular smooth muscle cells are dissociated due to abnormal spreading of basement membrane [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</a>].</div></li><li class="half_rhythm"><div>In one individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> porencephaly, focal disruption and a major increase in thickness of the basement membrane of skin capillaries were found [<a class="bk_pop" href="#col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</a>].</div></li></ul></div></div><div id="col4a1-dis.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>The number of <i>COL4A1</i> pathogenic variants is too small to explore <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> relationships.</p><p>However, all six <i>COL4A1</i> pathogenic variants associated with hereditary angiopathy, nephropathy, aneurysms, and muscle cramps (i.e., HANAC syndrome) are localized in exons 24 and 25 [<a class="bk_pop" href="#col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</a>, <a class="bk_pop" href="#col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</a>]. They affect glycine residues localized in a short 30-amino acid region of the protein, whereas all but one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> responsible for more severe brain disease, including porencephaly and small-vessel brain disease, are mostly distributed through exons 25 to 51 [<a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</p></div><div id="col4a1-dis.Penetrance"><h3>Penetrance</h3><p>Penetrance of <i>COL4A1</i>-related disorders is probably close to 100%, with expression varying in age of onset and severity of the clinical symptoms, even in the same family; however, these data need verification in larger cohort studies.</p></div><div id="col4a1-dis.Prevalence"><h3>Prevalence</h3><p>Prevalence of <i>COL4A1</i>-related disorders cannot be established as fewer than 100 families have been described.</p><p>No data on the prevalence of <i>COL4A1</i> pathogenic variants in persons with microscopic hematuria or renal cysts are available.</p><p>To date pathogenic variants have been reported in individuals of Dutch, Italian, French, German, American, Chinese, Spanish, and Japanese origin.</p></div></div><div id="col4a1-dis.Genetically_Related_Allelic_D"><h2 id="_col4a1-dis_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>COL4A1.</i></p></div><div id="col4a1-dis.Differential_Diagnosis"><h2 id="_col4a1-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p><b><i>COL4A2-</i>related porencephaly and intracerebral hemorrhages.</b> Seven <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>COL4A2</i> pathogenic variants have been characterized in individuals with either porencephaly (porencephaly type 2; OMIM <a href="http://omim.org/entry/614483" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614483</a>) or intracerebral hemorrhage (OMIM <a href="http://omim.org/entry/614519" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614519</a>). Neurologic presentation of individuals with porencephaly type 2 was similar to that observed in <i>COL4A1-</i>related porencephaly [<a class="bk_pop" href="#col4a1-dis.REF.yoneda.2012.86">Yoneda et al 2012</a>, <a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>]. Four patients presented with adult-onset intracerebral hemorrhage [<a class="bk_pop" href="#col4a1-dis.REF.jeanne.2012.91">Jeanne et al 2012</a>]. Variably present extracerebral symptoms included cerebellar and optic atrophy, cataracts, intracranial aneurysms, nephropathy, and myopathy [<a class="bk_pop" href="#col4a1-dis.REF.verbeek.2012.844">Verbeek et al 2012</a>, <a class="bk_pop" href="#col4a1-dis.REF.gunda.2014.500">Gunda et al 2014</a>].</p><p><a href="/books/n/gene/cadasil/"><b>CADASIL</b></a> (<i>c</i>erebral <i>a</i>utosomal <i>d</i>ominant <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy) is characterized by a history of migraine headaches with aura (30%-40% of individuals), mid-adult (30s-60s) onset of cerebrovascular disease, mood disturbance, apathy, cognitive disturbance progressing to dementia, and diffuse white-matter lesions and subcortical infarcts on neuroimaging. The pathologic hallmark of CADASIL is electron-dense granules in the media of arterioles that can often be identified by electron microscopic evaluation of skin biopsies. Mutation of <i>NOTCH3</i> causes CADASIL [<a class="bk_pop" href="#col4a1-dis.REF.joutel.1996.707">Joutel et al 1996</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Autosomal dominant retinal vasculopathy with cerebral leukodystrophy (RVCL)</b> (OMIM <a href="http://omim.org/entry/192315" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">192315</a>) is a microvascular endotheliopathy, which variably associates a retinal vasculopathy, migraine, Raynaud phenomenon, stroke, and dementia with onset in middle age [<a class="bk_pop" href="#col4a1-dis.REF.ophoff.2001.447">Ophoff et al 2001</a>].</p><p><i>H</i>ereditary <i>e</i>ndotheliopathy with <i>r</i>etinopathy, <i>n</i>ephropathy, and <i>s</i>troke (HERNS), a distinctive subtype of RVCL, is characterized by brain disease, kidney disease (hematuria and proteinuria), and Raynaud phenomenon. Ultrastructural alterations affecting the glomerular basement membrane and the basement membrane of capillaries in the brain and other tissues have been observed in HERNS [<a class="bk_pop" href="#col4a1-dis.REF.jen.1997.1322">Jen et al 1997</a>].</p><p>C terminus pathogenic variants in <i>TREX1</i> cause RVCL [<a class="bk_pop" href="#col4a1-dis.REF.richards.2007.1068">Richards et al 2007</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Porencephalic cysts</b> may occur after antenatal or neonatal parenchymal hemorrhagic infarction in the context of neonatal alloimmune thrombocytopenia; a coagulopathy like <a href="/books/n/gene/von-willebrand/">von Willebrand disease</a>, factor V deficiency (OMIM <a href="http://omim.org/entry/227400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">227400</a>), or factor X deficiency (OMIM <a href="http://omim.org/entry/227600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">227600</a>); maternal warfarin use; or thrombophilia (most often heterozygosity for factor V Leiden mutation) (see <a href="/books/n/gene/factor-v-leiden/">Factor V Leiden Thrombophilia</a>).</p><p><b>CARASIL</b> (<i>c</i>erebral <i>a</i>utosomal <i>r</i>ecessive <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eucoencephalopathy; Maeda-syndrome) is characterized by early-onset changes in the deep white matter of the brain observed on MRI and associated neurologic findings. The most frequent initial symptom is gait disturbance from spasticity beginning between ages 20 and 30 years; 23% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have stroke-like episodes before age 40 years. Mood changes (apathy and irritability), pseudobulbar palsy, and cognitive dysfunction begin between ages 20 and 50 years. The disease progresses slowly over the five to 20 years following the onset of neurologic symptoms. This rare disease is caused by pathogenic variants in <i>HTRA1</i>; inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>. CARASIL has been reported mostly in Japanese and Chinese families. See <a href="/books/n/gene/carasil/"><i>HTRA1</i> Disorder</a>.</p><p><b>Anophthalmia/microphthalmia (A/M).</b> Microphthalmia refers to a globe with a total axial length that is at least two standard deviations below the mean for age. Anophthalmia refers to complete absence of the globe in the presence of ocular adnexa (eyelids, conjunctiva, and lacrimal apparatus). A/M is a genetically heterogenous disorder that has been associated with pathogenic variants in more than 70 genes. <i>SOX2</i>, <i>OTX2</i>, and <i>FOXE3</i> are among the genes most commonly associated with A/M [<a class="bk_pop" href="#col4a1-dis.REF.chassaing.2014.326">Chassaing et al 2014</a>].</p></div><div id="col4a1-dis.Management"><h2 id="_col4a1-dis_Management_">Management</h2><div id="col4a1-dis.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>COL4A1</i>-related disorders, the following are recommended:</p><ul><li class="half_rhythm"><div>Brain MRI including T<sub>1</sub>-weighted saggital, T<sub>2</sub>-weighted axial, and FLAIR axial images</div></li><li class="half_rhythm"><div>Brain angiographic CT scan</div></li><li class="half_rhythm"><div>Ophthalmologic examination including fundoscopic examination and slit-lamp examination</div></li><li class="half_rhythm"><div>Kidney and liver ultrasound examination or CT</div></li><li class="half_rhythm"><div>Measurement of serum CK concentration</div></li><li class="half_rhythm"><div>Measurement of serum creatinine concentration and estimation of the glomerular filtration rate</div></li><li class="half_rhythm"><div>Evaluation for the presence of hematuria</div></li><li class="half_rhythm"><div>Electrocardiogram (ECG); echocardiography and ambulatory ECG monitoring in individuals presenting with palpitations</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="col4a1-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Hypertensive individuals must be treated to reduce the global risk of stroke.</p><p>Supportive care including practical help, emotional support, and counseling are appropriate for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and their families.</p><p>No specific support exists for individuals with <i>COL4A1</i>-related disorders.</p><ul><li class="half_rhythm"><div>Seizures are managed using standard protocols.</div></li><li class="half_rhythm"><div>Cataract surgery may be required for individuals with severe lens opacities.</div></li><li class="half_rhythm"><div>Glaucoma is initially treated with topical anti-glaucoma medication. Surgery is reserved for eyes that do not respond to medical therapy.</div></li><li class="half_rhythm"><div>Symptomatic paroxysmal supraventricular arrhythmia should be treated with antiarrhythmic drugs (beta blockers).</div></li><li class="half_rhythm"><div>Surgical or endovascular treatment should be discussed for asymptomatic intracranial aneurysms &#x0003e;10.0 mm in diameter.</div></li></ul></div><div id="col4a1-dis.Prevention_of_Primary_Manifes"><h3>Prevention of Primary Manifestations</h3><p>Avoidance of anticoagulant exposure and activities that involve an increased risk for head trauma may decrease the risk for intracerebral hemorrhage.</p></div><div id="col4a1-dis.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p>See <a href="#col4a1-dis.Prevention_of_Primary_Manifes">Prevention of Primary Manifestations</a>.</p></div><div id="col4a1-dis.Surveillance"><h3>Surveillance</h3><p>The interval at which individuals with <i>COL4A1</i>-related disorders should be seen for follow up depends on the severity and type of symptoms.</p><p>Annual clinical evaluation is reasonable.</p><p>Regular brain imaging can be proposed, especially to evaluate the size of asymptomatic cerebral aneurysms.</p></div><div id="col4a1-dis.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Smoking because it increases the global risk of stroke</div></li><li class="half_rhythm"><div>Hypertension because it increases the risk of stroke</div></li><li class="half_rhythm"><div>Sustained head pressure during birth or postnatal physical activities that may cause head trauma [<a class="bk_pop" href="#col4a1-dis.REF.gould.2006.1489">Gould et al 2006</a>]</div></li><li class="half_rhythm"><div>Anticoagulant use [<a class="bk_pop" href="#col4a1-dis.REF.gould.2006.1489">Gould et al 2006</a>]</div></li></ul></div><div id="col4a1-dis.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#col4a1-dis.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="col4a1-dis.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Cesarean delivery for pregnancies in which the fetus is at risk for a <i>COL4A1</i>-related disorder is recommended to prevent brain vascular injury attributable to birth trauma in newborns [<a class="bk_pop" href="#col4a1-dis.REF.gould.2006.1489">Gould et al 2006</a>].</p></div><div id="col4a1-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="col4a1-dis.Genetic_Counseling"><h2 id="_col4a1-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="col4a1-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>COL4A1</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="col4a1-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At least 50% of individuals diagnosed with a <i>COL4A1</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent [<a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>COL4A1</i>-related disorder may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is estimated to be at least 27% [<a class="bk_pop" href="#col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the pathogenic variant identified in the proband, medical record review, brain imaging by MRI, and ophthalmologic evaluation.</div></li><li class="half_rhythm"><div>If the <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with a <i>COL4A1</i>-related disorder may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents: if a parent of the proband is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>Although <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>COL4A1</i>-related disorders is probably close to 100%, age of onset and severity of the clinical symptoms vary, even in the same family.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk (for the disorder) because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a <i>COL4A1</i>-related disorder has a 50% chance of inheriting the <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="col4a1-dis.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="col4a1-dis.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>COL4A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for a <i>COL4A1</i>-related disorder are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="col4a1-dis.Resources"><h2 id="_col4a1-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Porencephaly-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Porencephaly Information Page</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>Fili&#x000e8;re Orphan Kidney Diseases</b></div><div>CHRU de Montpellier - H&#x000f4;pital Arnaud de Villeneuve</div><div>371, Avenue du Doyen Gaston Giraud</div><div>France</div><div><b>Phone:</b> 33 4 67 33 55 99</div><div><b>Email:</b> contact@filiereorkid.com</div><div><a href="http://www.filiereorkid.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.filiereorkid.com</a></div></li><li class="half_rhythm"><div><b>Kidney Foundation of Canada</b></div><div>310-5160 Decarie Blvd.</div><div>Montreal Ontario H3X 2H9 </div><div>Canada</div><div><b>Phone:</b> 800-361-7494 (toll-free); 514-369-4806</div><div><b>Fax:</b> 514-369-2472 </div><div><b>Email:</b> info@kidney.ca</div><div><a href="http://www.kidney.on.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kidney.ca</a></div></li><li class="half_rhythm"><div><b>MAGNUM - Migraine Awareness Group: A National Understanding for Migraineurs</b></div><div>The National Migraine Association</div><div>100 North Union Street</div><div>Suite B</div><div>Alexandria VA 22314</div><div><b>Phone:</b> 703-349-1929</div><div><b>Fax:</b> 800-884-1300 (toll-free)</div><div><b>Email:</b> comments@migraines.org</div><div><a href="http://www.migraines.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.migraines.org</a></div></li><li class="half_rhythm"><div><b>National Center on Birth Defects and Developmental Disabilities</b></div><div>1600 Clifton Road</div><div>MS E-87</div><div>Atlanta GA 30333</div><div><b>Phone:</b> 800-232-4636 (toll-free); 888-232-6348 (TTY)</div><div><b>Email:</b> cdcinfo@cdc.gov</div><div><a href="http://www.cdc.gov/ncbddd/dd/ddmr.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://nei.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">https://nei.nih.gov/</a></div></li><li class="half_rhythm"><div><b>National Kidney Foundation (NKF)</b></div><div>30 East 33rd Street</div><div>New York NY 10016</div><div><b>Phone:</b> 800-622-9010 (toll-free); 212-889-2210</div><div><b>Email:</b> info@kidney.org</div><div><a href="http://www.kidney.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kidney.org</a></div></li></ul></div><div id="col4a1-dis.Molecular_Genetics"><h2 id="_col4a1-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="col4a1-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>COL4A1-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7046/table/col4a1-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__col4a1-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_col4a1-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_col4a1-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_col4a1-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_col4a1-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_col4a1-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_col4a1-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_col4a1-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1282" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>COL4A1</i></a></td><td headers="hd_b_col4a1-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1282" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">13q34</a></td><td headers="hd_b_col4a1-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P02462" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Collagen alpha-1(IV) chain</a></td><td headers="hd_b_col4a1-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/COL4A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL4A1 @ LOVD</a></td><td headers="hd_b_col4a1-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL4A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL4A1</a></td><td headers="hd_b_col4a1-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=COL4A1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COL4A1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="col4a1-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="col4a1-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for COL4A1-Related Disorders (<a href="/omim/120130,175780,607595,611773" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7046/table/col4a1-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__col4a1-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/120130" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">120130</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">COLLAGEN, TYPE IV, ALPHA-1; COL4A1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/175780" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">175780</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607595" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607595</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">none found</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611773" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611773</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>COL4A1</i> consists of 52 exons spanning roughly 158 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK7046/#col4a1-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Most of the sequence alterations in <i>COL4A1</i> are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (leading to the substitution of a glycine residue in the collagenous <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein) located between exons 24 and 49. One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> affects the start codon. One small <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> is located within the non-collagenous domain (NC-1) located at the C-terminal end of the protein.</p><div id="col4a1-dis.T.selected_col4a1_pathogenic" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>COL4A1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK7046/table/col4a1-dis.T.selected_col4a1_pathogenic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__col4a1-dis.T.selected_col4a1_pathogenic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1A&#x0003e;T</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met1Leu</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_3" rowspan="19" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_001845.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001845<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/entrez/viewer.fcgi?val=NP_001836.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001836<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1493G&#x0003e;T</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly498Val</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1528G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly510Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1555G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly519Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1583G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly528Glu</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1769G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly562Glu</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2122G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly708Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2159G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly720Asp</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2245G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly749Ser</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2317G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly773</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2345G&#x0003e;C</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly782Ala</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2413G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly805Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3389G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1130Asp</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3706G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1236Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3976G&#x0003e;A</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1326Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4267G&#x0003e;C</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1423Arg</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4582-4586dupCCCAT</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met1529IlefsTer15</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4611_4612insG</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr1537fs</td></tr><tr><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4738G&#x0003e;C</td><td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1580Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>COL4A1</i> encodes the alpha 1 chain of type IV collagen. Type IV collagen is the main component of basement membranes. The six different type IV collagen alpha chains described all consist of a small amino-terminal 7S <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, a large collagenous domain containing the classic Gly-X-Y repeat, and a carboxy-terminal non-collagenous NC1 domain. Specific interactions between NC1 domains initiate the formation of only three different trimers: &#x003b1;1&#x003b1;1&#x003b1;2, &#x003b1;3&#x003b1;4&#x003b1;5, and &#x003b1;5&#x003b1;5&#x003b1;6. Glycine residues play an important role for the stabilization of collagenous triple helical domain. Isoforms of type IV collagen display a tissue- and developmental-specific distribution that explains the heterogeneity of basement membrane composition. The &#x003b1;1&#x003b1;1&#x003b1;2 (IV) trimer is widely expressed, whereas the &#x003b1;3&#x003b1;4&#x003b1;5 (IV) and &#x003b1;5&#x003b1;5&#x003b1;6 (IV) trimers display a more tissue-restricted expression.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most of the pathogenic variants reported in <i>COL4A1</i>-related disorders affect highly conserved glycine residues within the collagenous <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein. These amino-acid changes are predicted to result in detrimental effect on collagen &#x003b1;1&#x003b1;1&#x003b1;2 (IV) triple helix formation and stability. Six pathogenic variants are localized in the non-collagenous (NC1) domain that contains recognition sequences involved in the collagen &#x003b1;1&#x003b1;1&#x003b1;2 (IV) triple helix assembly. One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (p.Met1Leu) affects the start codon, resulting in an unknown effect on protein synthesis (see <a class="figpopup" href="/books/NBK7046/table/col4a1-dis.T.selected_col4a1_pathogenic/?report=objectonly" target="object" rid-figpopup="figcol4a1disTselectedcol4a1pathogenic" rid-ob="figobcol4a1disTselectedcol4a1pathogenic">Table 2</a>). Two pathogenic variants affect splice sites, leading to <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions as demonstrated by <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> analysis.</p></div><div id="col4a1-dis.References"><h2 id="_col4a1-dis_References_">References</h2><div id="col4a1-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.alamowitch.2009.1873">Alamowitch S, Plaisier E, Favrole P, Prost C, Chen Z, Van Agtmael T, Marro B, Ronco P. Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:1873–82.</span> [<a href="/pmc/articles/PMC2881859/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2881859</span></a>] [<a href="/pubmed/19949034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19949034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.ayrignac.2015.284">Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Mar&#x000e9;chal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P. Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:284–92.</span> [<a href="/pubmed/25527826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25527826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.breedveld.2006.490">Breedveld G, de Coo RF, Lequin MH, Arts WFM, Heuting P, Gould DB, John SWM, Oostra B, Mancini GMS. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:490–5.</span> [<a href="/pmc/articles/PMC2593028/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2593028</span></a>] [<a href="/pubmed/16107487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16107487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.chassaing.2014.326">Chassaing N, Causse A, Vigouroux A, Delahaye A, Alessandri JL, Boespflug-Tanguy O, Boute-Benejean O, Dollfus H, Duban-Bedu B, Gilbert-Dussardier B, Giuliano F, Gonzales M, Holder-Espinasse M, Isidor B, Jacquemont ML, Lacombe D, Martin-Coignard D, Mathieu-Dramard M, Odent S, Picone O, Pinson L, Quelin C, Sigaudy S, Toutain A, Thauvin-Robinet C, Kaplan J, Calvas P. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">86</span>:326–34.</span> [<a href="/pubmed/24033328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24033328</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.coupry.2010.483">Coupry I, Sibon I, Mortemousque B, Rouanet F, Mine M, Goizet C. Ophthalmological features associated with COL4A1 mutations. <span><span class="ref-journal">Arch Ophthalmol. </span>2010;<span class="ref-vol">128</span>:483–9.</span> [<a href="/pubmed/20385946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20385946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.gale.2016.1908">Gale DP, Oygar DD, Lin F, Oygar PD, Khan N, Connor TM, Lapsley M, Maxwell PH, Neild GH. A novel COL4A1 frameshift mutation in familial kidney disease: the importance of the C-terminal NC1 domain of type IV collagen. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2016;<span class="ref-vol">31</span>:1908–14.</span> [<a href="/pmc/articles/PMC5091614/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5091614</span></a>] [<a href="/pubmed/27190376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27190376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.gould.2005.1167">Gould DB, Phalan FC, Breedveld GJ. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. <span><span class="ref-journal">Science. </span>2005;<span class="ref-vol">308</span>:1167–71.</span> [<a href="/pubmed/15905400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15905400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.gould.2006.1489">Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, Bousser MG, Heuting P, Miner JH, Tournier-Lasserve E, John SWM. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">354</span>:1489–96.</span> [<a href="/pubmed/16598045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16598045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.gunda.2014.500">Gunda B, Mine M, Kov&#x000e1;cs T, Horny&#x000e1;k C, Bereczki D, V&#x000e1;rallyay G, Rudas G, Audrezet MP, Tournier-Lasserve E. COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy. <span><span class="ref-journal">J Neurol. </span>2014;<span class="ref-vol">261</span>:500–3.</span> [<a href="/pubmed/24390199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24390199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.jeanne.2012.91">Jeanne M, Labelle-Dumais C, Jorgensen J, Kauffman WB, Mancini GM, Favor J, Valant V, Greenberg SM, Rosand J, Gould DB. COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:91–101.</span> [<a href="/pmc/articles/PMC3257894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257894</span></a>] [<a href="/pubmed/22209247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22209247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.jen.1997.1322">Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, Baloh RW. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:1322–30.</span> [<a href="/pubmed/9371916" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9371916</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.john.2015.19">John S, Jehi L, Manno EM, Conway DS, Uchino K. COL4A1 gene mutation--beyond a vascular syndrome. <span><span class="ref-journal">Seizure. </span>2015;<span class="ref-vol">31</span>:19–21.</span> [<a href="/pubmed/26362372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26362372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.joutel.1996.707">Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, C&#x000e9;cillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">383</span>:707–10.</span> [<a href="/pubmed/8878478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8878478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.livingston.2011.227">Livingston J, Doherty D, Orcesi S, Tonduti D, Piechiecchio A, La Piana R, Tournier-Lasserve E, Majumdar A, Tomkins S, Rice G, Kneen R, van der Knaap M, Crow Y. COL4A1 mutations associated with a characteristic pattern of intracranial calcification. <span><span class="ref-journal">Neuropediatrics. </span>2011;<span class="ref-vol">42</span>:227–33.</span> [<a href="/pubmed/22134833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22134833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.meuwissen.2015.843">Meuwissen ME, Halley DJ, Smit LS, Lequin MH, Cobben JM, de Coo R, van Harssel J, Sallevelt S, Woldringh G, van der Knaap MS, de Vries LS, Mancini GM. The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature. <span><span class="ref-journal">Genet Med. </span>2015;<span class="ref-vol">17</span>:843–53.</span> [<a href="/pubmed/25719457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25719457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.ophoff.2001.447">Ophoff RA, DeYoung J, Service SK. Hereditary vascular retinopathy, cerebrovascular vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:447–53.</span> [<a href="/pmc/articles/PMC1235317/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1235317</span></a>] [<a href="/pubmed/11438888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11438888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.plaisier.2010.2550">Plaisier E, Chen Z, Gekeler F, Benhassine S, Dahan K, Marro B, Alamowitch S, Paques M, Ronco P. Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2550–5.</span> [<a href="/pubmed/20818663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20818663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.plaisier.2007.2687">Plaisier E, Gribouval O, Alamowitch S, Mougenot B, Prost C, Verpont MC, Marro B, Desmettre T, Cohen SY, Roullet E, Dracon M, Fardeau M, Van Agtmael T, Kerjaschki D, Antignac C, Ronco P. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:2687–95.</span> [<a href="/pubmed/18160688" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18160688</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.richards.2007.1068">Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, Liszewski MK, Barilla-Labarca ML, Terwindt GM, Kasai Y, McLellan M, Grand MG, Vanmolkot KR, de Vries B, Wan J, Kane MJ, Mamsa H, Schafer R, Stam AH, Haan J, de Jong PT, Storimans CW, van Schooneveld MJ, Oosterhuis JA, Gschwendter A, Dichgans M, Kotschet KE, Hodgkinson S, Hardy TA, Delatycki MB, Hajj-Ali RA, Kothari PH, Nelson SF, Frants RR, Baloh RW, Ferrari MD, Atkinson JP. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1068–70.</span> [<a href="/pubmed/17660820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17660820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.r_dahl.2013.946">R&#x000f8;dahl E, Knappskog PM, Majewski J, Johansson S, Telstad W, Kr&#x000e5;kenes J, Boman H. Variants of anterior segment dysgenesis and cerebral involvement in a large family with a novel COL4A1 mutation. <span><span class="ref-journal">Am J Ophthalmol. </span>2013;<span class="ref-vol">155</span>:946–53.</span> [<a href="/pubmed/23394911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23394911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.shah.2012.569">Shah S, Ellard S, Kneen R, Lim M, Osborne N, Rankin J, Stoodley N, van der Knaap M, Whitney A, Jardine P. Childhood presentation of COL4A1 mutations. <span><span class="ref-journal">Dev Med Child Neurol. </span>2012;<span class="ref-vol">54</span>:569–74.</span> [<a href="/pubmed/22574627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22574627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.shah.2010.182">Shah S, Kumar Y, McLean B, Churchill A, Stoodley N, Rankin J, Rizzu P, van der Knaap M, Jardine P. A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2010;<span class="ref-vol">14</span>:182–7.</span> [<a href="/pubmed/19477666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19477666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.sibon.2007.177">Sibon I, Coupry I, Menegon P, Bouchet JP, Gorry P, Burgelin I, Calvas P, Orignac I, Dousset V, Lacombe D, Orgogozo JM, Arveiler B, Goizet C. COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">62</span>:177–84.</span> [<a href="/pubmed/17696175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17696175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.vahedi.2007.1461">Vahedi K, Kubi N, Boukobza M, Arnoult M, Massin P, Gould DB, Tournier-Lasserve E, Bousser MG. COL4A1 mutation in patient with sporadic recurrent intracerebral hemorrhage. <span><span class="ref-journal">Stroke. </span>2007;<span class="ref-vol">38</span>:1461–4.</span> [<a href="/pubmed/17379824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17379824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap MS, Smit LM, Barkhof F, Pijnenburg YA, Zweegman S, Niessen HW, Imhof S, Heutink P. Neonatal porencephaly and adult stroke related to mutations in collagen IV A1. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:504–11.</span> [<a href="/pubmed/16374828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16374828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.verbeek.2012.844">Verbeek E, Meuwissen ME, Verheijen FW, Govaert PP, Licht DJ, Kuo DS, Poulton CJ, Schot R, Lequin MH, Dudink J, Halley DJ, de Coo RI, den Hollander JC, Oegema R, Gould DB, Mancini GM. COL4A2 mutation associated with familial porencephaly and small-vessel disease. <span><span class="ref-journal">Eur J Hum Genet. </span>2012;<span class="ref-vol">20</span>:844–51.</span> [<a href="/pmc/articles/PMC3400734/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3400734</span></a>] [<a href="/pubmed/22333902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22333902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.xia.2014.97">Xia XY, Li N, Cao X, Wu QY, Li TF, Zhang C, Li WW, Cui YX, Li XJ, Xue CY. A novel COL4A1 gene mutation results in autosomal dominant non-syndromic congenital cataract in a Chinese family. <span><span class="ref-journal">BMC Med Genet. </span>2014;<span class="ref-vol">15</span>:97.</span> [<a href="/pmc/articles/PMC4236509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4236509</span></a>] [<a href="/pubmed/25124159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25124159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.yoneda.2012.86">Yoneda Y, Haginoya K, Arai H, Yamaoka S, Tsurusaki Y, Doi H, Miyake N, Yokochi K, Osaka H, Kato M, Matsumoto N, Saitsu H. De novo and inherited mutations in COL4A2, encoding the type IV collagen &#x003b1;2 chain cause porencephaly. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:86–90.</span> [<a href="/pmc/articles/PMC3257897/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257897</span></a>] [<a href="/pubmed/22209246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22209246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.yoneda.2013.48">Yoneda Y, Haginoya K, Kato M, Osaka H, Yokochi K, Arai H, Kakita A, Yamamoto T, Otsuki Y, Shimizu S, Wada T, Koyama N, Mino Y, Kondo N, Takahashi S, Hirabayashi S, Takanashi J, Okumura A, Kumagai T, Hirai S, Nabetani M, Saitoh S, Hattori A, Yamasaki M, Kumakura A, Sugo Y, Nishiyama K, Miyatake S, Tsurusaki Y, Doi H, Miyake N, Matsumoto N, Saitsu H. Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly. <span><span class="ref-journal">Ann Neurol. </span>2013;<span class="ref-vol">73</span>:48–57.</span> [<a href="/pubmed/23225343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23225343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="col4a1-dis.REF.zenteno.2014.1789">Zenteno JC, Crespi J, Buentello-Volante B, Buil JA, Bassaganyas F, Vela-Segarra JI, Diaz-Cascjosa J, Marieges MT. Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosity. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>2014;<span class="ref-vol">252</span>:1789–94.</span> [<a href="/pubmed/25228067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25228067</span></a>]</div></li></ul></div></div><div id="col4a1-dis.Chapter_Notes"><h2 id="_col4a1-dis_Chapter_Notes_">Chapter Notes</h2><div id="col4a1-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 July 2016 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 March 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 June 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>27 February 2009 (ep) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK7046</span><span class="label">PMID: <a href="/pubmed/20301768" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301768</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/oi/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hdls/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK7046&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK7046/?report=reader">PubReader</a></li><li><a href="/books/NBK7046/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK7046" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK7046" style="display:none" title="Cite this Page"><div class="bk_tt">Plaisier E, Ronco P. COL4A1-Related Disorders. 2009 Jun 25 [Updated 2016 Jul 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK7046/pdf/Bookshelf_NBK7046.pdf">PDF version of this page</a> (669K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#col4a1-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#col4a1-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#col4a1-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#col4a1-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#col4a1-dis.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#col4a1-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#col4a1-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#col4a1-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#col4a1-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#col4a1-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#col4a1-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#col4a1-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1282[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">COL4A1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK7046+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1533148" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1533148" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1533148" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1533148" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19949034" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.</a><span class="source">[Neurology. 2009]</span><div class="brieflinkpop offscreen_noflow">Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Alamowitch S, Plaisier E, Favrole P, Prost C, Chen Z, Van Agtmael T, Marro B, Ronco P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 2009 Dec 1; 73(22):1873-82. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31536185" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">de Boer I, Pelzer N, Terwindt G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20818663" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain.</a><span class="source">[Am J Med Genet A. 2010]</span><div class="brieflinkpop offscreen_noflow">Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Plaisier E, Chen Z, Gekeler F, Benhassine S, Dahan K, Marro B, Alamowitch S, Paques M, Ronco P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2010 Oct; 152A(10):2550-5. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25873210" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Two families with novel missense mutations in COL4A1: When diagnosis can be missed.</a><span class="source">[J Neurol Sci. 2015]</span><div class="brieflinkpop offscreen_noflow">Two families with novel missense mutations in COL4A1: When diagnosis can be missed.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Giorgio E, Vaula G, Bosco G, Giacone S, Mancini C, Calcia A, Cavalieri S, Di Gregorio E, Rigault De Longrais R, Leombruni S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2015 May 15; 352(1-2):99-104. Epub 2015 Apr 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21157337" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease.</a><span class="source">[Curr Opin Neurol. 2011]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vahedi K, Alamowitch S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Opin Neurol. 2011 Feb; 24(1):63-8. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301768" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301768" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04175a39a66ee2ba2c2094">COL4A1-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">COL4A1-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:13:46-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88F16AE03FE8E1000000000A3C0398&amp;ncbi_session=CE88F16AE0417591_2620SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK7046%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK7046&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK7046/&amp;ncbi_pagename=COL4A1-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88F16AE0417591_2620SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>